Trial Outcomes & Findings for Near-infrared Software Performance Study (NCT NCT02200458)
NCT ID: NCT02200458
Last Updated: 2015-03-09
Results Overview
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
62 participants
Primary outcome timeframe
One day
Results posted on
2015-03-09
Participant Flow
Participant milestones
| Measure |
VeinViewer
Vascular imaging technology will be used to visualize peripheral vasculature.
VeinViewer
|
|---|---|
|
Overall Study
STARTED
|
62
|
|
Overall Study
COMPLETED
|
62
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Near-infrared Software Performance Study
Baseline characteristics by cohort
| Measure |
VeinViewer
n=62 Participants
Vascular imaging technology will be used to visualize peripheral vasculature.
VeinViewer
|
|---|---|
|
Age, Continuous
|
37.5 Years
STANDARD_DEVIATION 10.8 • n=5 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
41 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
62 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
53 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Height
|
168.7 CM
STANDARD_DEVIATION 10.5 • n=5 Participants
|
|
Weight
|
83.2 kg
STANDARD_DEVIATION 17.6 • n=5 Participants
|
|
Fitzpatrick
|
20.2 Points
STANDARD_DEVIATION 7 • n=5 Participants
|
PRIMARY outcome
Timeframe: One dayOutcome measures
| Measure |
VeinViewer
n=62 Participants
Vascular imaging technology will be used to visualize peripheral vasculature.
VeinViewer
|
|---|---|
|
Number of Participants for Whom Successful Visualization of Vasculature Was Achieved
|
62 participants
|
Adverse Events
VeinViewer
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Clinical Affairs Manager
Christie Medical Holdings, Inc.
Phone: 901-721-0330
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place